⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
prnewswire.com
TLX
MYGN
Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
prnewswire.com
SPGI
VRT
LITE
COHR
SATS
NSSC
ALEX
MU
LRCX
AMAT
GEV
PYPL
AIG
MET
TGT
MTCH
MOH
LW
PAYC
SOLS
SITM
MOG.A
IDCC
VICR
CTRE
GTM
ASGN
KMPR
VSEC
AGX
RITM
LYFT
LAUR
LTH
LIF
SPHR
PLAY
SXC
AHRT
INN
KREF
BLMN
MYGN
CARS
ANGI
University of Utah to expand innovation support across West in partnership with USPTO
prnewswire.com
MYGN
Myriad Commercially Launches Precise MRD with Select Community Oncologists
globenewswire.com
MYGN
Myriad Commercially Launches Precise MRD with Select Community Oncologists
globenewswire.com
MYGN
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
globenewswire.com
MYGN
Diality Appoints Peter Donato as Chief Financial Officer
businesswire.com
TFX
STIM
MYGN
Form 8-K
sec.gov
MYGN
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
globenewswire.com
MYGN
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
globenewswire.com
MYGN